View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Alpelisib 300 / Fulvestrant 500, Breast Cancer, Cycle 2+
Protocol-ID: 1621 V1.0 (Mini), ALPE300/FLVS500, Breast Ca, C2+Indication(s)
- Breast Cancer (HR+, PIK3CA mutation); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 03.09.2020